5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
BUY | BUY | SELL | SELL | SELL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 2.33▲ | 2.33▲ | 2.37▼ | 2.31▲ | 2.91▼ |
MA10 | 2.34▲ | 2.34▲ | 2.34▲ | 2.47▼ | 4.23▼ |
MA20 | 2.31▲ | 2.30▲ | 2.32▲ | 3.00▼ | 9.71▼ |
MA50 | 2.32▲ | 2.39▼ | 2.48▼ | 5.00▼ | 251.92▼ |
MA100 | 2.41▼ | 2.63▼ | 3.14▼ | 9.86▼ | N/A |
MA200 | 2.65▼ | 3.75▼ | 4.50▼ | 145.29▼ | N/A |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | 0.007▲ | 0.014▲ | 0.025▲ | 0.110▲ | 25.043▲ |
RSI | 53.436▲ | 51.384▲ | 47.849▼ | 30.900▼ | 18.398▼ |
STOCH | 55.952 | 55.952 | 68.452 | 16.402▼ | 3.767▼ |
WILL %R | -38.095 | -38.095 | -36.364 | -80.000▼ | -98.248▼ |
CCI | 62.073 | 61.990 | 74.414 | -67.365 | -86.701 |
Tuesday, April 29, 2025 09:16 AM
Northstrive Biosciences Inc. (“Northstrive”), a subsidiary of PMGC Holdings Inc. (NASDAQ: ELAB) (the “Company,” “PMGC,” “we,” or “our”), today announced the filing of four novel patent applications ...
|
Tuesday, April 29, 2025 05:16 AM
EL-22 in Animals: Fusion Protein of Myo-2 for Use in Encouraging Muscle Growth in Animals (Patent Application No. 19/191,246). EL-32 in Obesity as Monotherapy and Combination with GLP-1: Updated ...
|
Tuesday, April 29, 2025 01:13 AM
NEWPORT BEACH, Calif. – Northstrive Biosciences Inc., a subsidiary of PMGC Holdings Inc. (NASDAQ: ELAB), currently valued at $1.61 million in market capitalization, has filed four new patent ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
01/05/25 | 2.365 | 2.365 | 2.36 | 2.36 | 80,748 |
30/04/25 | 2.34 | 2.45 | 2.14 | 2.29 | 142,537 |
29/04/25 | 2.30 | 2.38 | 2.27 | 2.34 | 101,801 |
28/04/25 | 2.28 | 2.3795 | 2.16 | 2.28 | 326,679 |
25/04/25 | 2.26 | 2.71 | 2.21 | 2.26 | 816,920 |
24/04/25 | 2.93 | 2.95 | 2.15 | 2.22 | 5,398,239 |
23/04/25 | 2.89 | 2.96 | 2.7001 | 2.91 | 65,246 |
22/04/25 | 2.64 | 2.86 | 2.64 | 2.79 | 58,456 |
21/04/25 | 2.57 | 2.71 | 2.48 | 2.68 | 64,533 |
17/04/25 | 2.58 | 2.62 | 2.48 | 2.60 | 46,762 |
|
|
||||
|
|
||||
|
|